l-ornithine l-aspartate + silymarin

Hepatig DS is a combination medication developed by Tigris Lifesciences for the management of various liver disorders within the field of gastroenterology. It typically contains L-ornithine L-aspartate and silymarin. L-ornithine L-aspartate works by reducing blood ammonia levels through the stimulation of the urea cycle and glutamine synthesis, which is particularly beneficial in hepatic encephalopathy. Silymarin, a flavonoid complex extracted from milk thistle, acts as an antioxidant and hepatoprotective agent by stabilizing liver cell membranes and promoting protein synthesis to aid in liver regeneration. The DS designation indicates a Double Strength formulation, providing higher concentrations of the active ingredients compared to the standard version.

Brand names

Hepatig DS